Lean Life Science is an organisation dedicated to catalysing innovation in life science through partnership.

Focused on leveraging its unique collaboration of expertise spanning the R&D ecosystem, LLS uses its Innovation Development Framework™ (IDF) to provide the critical insights and validated delivery plans needed to accelerate the translational journey of life science innovations into highly desirable, de-risked, investable opportunities.

A unique collaboration of expertise spanning the R&D ecosystem



Founder and CEO

12 years in investment banking raising ~$500m for VCs  & SMEs.  As Director of the Alderley Park Accelerator, he has supported the creation & growth of over 200 life science companies. In 2021 as Founder/Director of Alderley Park Oncology Development Programme participants raised ~£40million


Partnerships, Operations​

30 years of oncology clinical drug development experience including 25 years at AstraZeneca and successfully founding /exiting an oncology focused clinical CRO which was recently acquired by a US-based CRO​


Coach & Advisor​

Life science consultant, motivated by the opportunity to translate basic research into clinical application in a way that benefits patients most effectively.  >30-year track record of drug discovery and development in the pharmaceutical, biotechnology and academic sectors.  Most recently as Director of Translational Science at CellCentric Ltd.

Dr Lynne Trowbridge​


Senior business communications expert passionate about conveying the value of cutting-edge science.
With over 25 years’ experience of working across the global life science sector, Lynne has hands-on experience of research, product development, sales, marketing, business and issues communications.
Lynne specialises in all aspects of business communications, branding, and integrated marketing and has supported numerous tools, diagnostics, pharma and CRO organisations.

Claire Gogarty

Executive Support

With over 8 years of providing high-level professional support within academia, publishing, and corporate finance, she has a proven track-record in project management, administrative functions, managing client relationships, and assisting executive teams.


Lucy Padget

Patent Attorney
Alembria Intellectual Property

Lucy is a Director and co-founding Partner at the boutique patent firm, Alembia Intellectual Property Limited, specialising in chemistry, pharmaceutical and life science patent matters. She is a qualified European and Chartered (UK) patent attorney with a strong background in organic and medicinal chemistry, particularly in the oncology area.

Lucy holds more than two decades’ worth of experience of the pharmaceutical industry, and her patent practice spans the lifetime of a patent, from invention capture to IP litigation. She’s created patent families from projects originating in Europe, US and China, provided input and advice for numerous business development deals, and managed multijurisdictional patent litigation relating to an oncology blockbuster product.

Liam McIlveen

Intellectual Property
Mackle Legal

Offering legal support to Lean Life Science, Liam is a senior lawyer with unique experience in the pharmaceutical industry. He has successfully delivered all types of legal work, with a particular specialism in commercial and business development transactions. Furthermore, Liam has managed IP licences, collaborations, product disposals and acquisitions, M&A projects, and many other commercial and R&D deals. He also has experience of disputes, investigations, competition law and other commercial issues.

Mary Duke

Finance Director
Integral Finance

An experienced Finance Director, Mary has background with AstraZeneca as the finance lead on drug product teams from late development through to on-market. Now works as Portfolio Finance Director for emerging companies in the Life Sciences sector as part of the Integral Finance Partnership.